List of Chapters/Sections(Table Of Content)
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Nuclear Medicine/Radiopharmaceuticals Revenue
1.4 Market Analysis by Type
1.4.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Diagnostic
1.4.3 Therapeutic
1.5 Market by Application
1.5.1 Global Nuclear Medicine/Radiopharmaceuticals Market Share by Application: 2022-2027
1.5.2 Oncology
1.5.3 Thyroid
1.5.4 Cardiology
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Nuclear Medicine/Radiopharmaceuticals Market
1.8.1 Global Nuclear Medicine/Radiopharmaceuticals Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Nuclear Medicine/Radiopharmaceuticals Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Nuclear Medicine/Radiopharmaceuticals Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Nuclear Medicine/Radiopharmaceuticals Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Region (2016-2021)
3.2 Global Nuclear Medicine/Radiopharmaceuticals Sales Revenue Market Share by Region (2016-2021)
3.3 North America Nuclear Medicine/Radiopharmaceuticals Sales Volume
3.3.1 North America Nuclear Medicine/Radiopharmaceuticals Sales Volume Growth Rate (2016-2021)
3.3.2 North America Nuclear Medicine/Radiopharmaceuticals Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume
3.4.1 East Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Nuclear Medicine/Radiopharmaceuticals Sales Volume (2016-2021)
3.5.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Nuclear Medicine/Radiopharmaceuticals Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume (2016-2021)
3.6.1 South Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume (2016-2021)
3.7.1 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Nuclear Medicine/Radiopharmaceuticals Sales Volume (2016-2021)
3.8.1 Middle East Nuclear Medicine/Radiopharmaceuticals Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Nuclear Medicine/Radiopharmaceuticals Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Nuclear Medicine/Radiopharmaceuticals Sales Volume (2016-2021)
3.9.1 Africa Nuclear Medicine/Radiopharmaceuticals Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Nuclear Medicine/Radiopharmaceuticals Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Nuclear Medicine/Radiopharmaceuticals Sales Volume (2016-2021)
3.10.1 Oceania Nuclear Medicine/Radiopharmaceuticals Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Nuclear Medicine/Radiopharmaceuticals Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Nuclear Medicine/Radiopharmaceuticals Sales Volume (2016-2021)
3.11.1 South America Nuclear Medicine/Radiopharmaceuticals Sales Volume Growth Rate (2016-2021)
3.11.2 South America Nuclear Medicine/Radiopharmaceuticals Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Nuclear Medicine/Radiopharmaceuticals Sales Volume (2016-2021)
3.12.1 Rest of the World Nuclear Medicine/Radiopharmaceuticals Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Nuclear Medicine/Radiopharmaceuticals Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Nuclear Medicine/Radiopharmaceuticals Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Nuclear Medicine/Radiopharmaceuticals Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Nuclear Medicine/Radiopharmaceuticals Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Nuclear Medicine/Radiopharmaceuticals Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Nuclear Medicine/Radiopharmaceuticals Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Nuclear Medicine/Radiopharmaceuticals Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Nuclear Medicine/Radiopharmaceuticals Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Nuclear Medicine/Radiopharmaceuticals Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Nuclear Medicine/Radiopharmaceuticals Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Type (2016-2021)
14.2 Global Nuclear Medicine/Radiopharmaceuticals Sales Revenue Market Share by Type (2016-2021)
14.3 Global Nuclear Medicine/Radiopharmaceuticals Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption Volume by Application (2016-2021)
15.2 Global Nuclear Medicine/Radiopharmaceuticals Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Nuclear Medicine/Radiopharmaceuticals Business
16.1 China Isotope & Radiation
16.1.1 China Isotope & Radiation Company Profile
16.1.2 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Product Specification
16.1.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Dongcheng
16.2.1 Dongcheng Company Profile
16.2.2 Dongcheng Nuclear Medicine/Radiopharmaceuticals Product Specification
16.2.3 Dongcheng Nuclear Medicine/Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Jaco
16.3.1 Jaco Company Profile
16.3.2 Jaco Nuclear Medicine/Radiopharmaceuticals Product Specification
16.3.3 Jaco Nuclear Medicine/Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Ciaeriar
16.4.1 Ciaeriar Company Profile
16.4.2 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Product Specification
16.4.3 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Advanced Molecular-imaging Solution
16.5.1 Advanced Molecular-imaging Solution Company Profile
16.5.2 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Product Specification
16.5.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Shanghai Atom Kexing
16.6.1 Shanghai Atom Kexing Company Profile
16.6.2 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Product Specification
16.6.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Nuclear Medicine/Radiopharmaceuticals Manufacturing Cost Analysis
17.1 Nuclear Medicine/Radiopharmaceuticals Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceuticals
17.4 Nuclear Medicine/Radiopharmaceuticals Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Nuclear Medicine/Radiopharmaceuticals Distributors List
18.3 Nuclear Medicine/Radiopharmaceuticals Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Nuclear Medicine/Radiopharmaceuticals (2022-2027)
20.2 Global Forecasted Revenue of Nuclear Medicine/Radiopharmaceuticals (2022-2027)
20.3 Global Forecasted Price of Nuclear Medicine/Radiopharmaceuticals (2016-2027)
20.4 Global Forecasted Production of Nuclear Medicine/Radiopharmaceuticals by Region (2022-2027)
20.4.1 North America Nuclear Medicine/Radiopharmaceuticals Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Nuclear Medicine/Radiopharmaceuticals Production, Revenue Forecast (2022-2027)
20.4.3 Europe Nuclear Medicine/Radiopharmaceuticals Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Nuclear Medicine/Radiopharmaceuticals Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Nuclear Medicine/Radiopharmaceuticals Production, Revenue Forecast (2022-2027)
20.4.7 Africa Nuclear Medicine/Radiopharmaceuticals Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Nuclear Medicine/Radiopharmaceuticals Production, Revenue Forecast (2022-2027)
20.4.9 South America Nuclear Medicine/Radiopharmaceuticals Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Nuclear Medicine/Radiopharmaceuticals Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Nuclear Medicine/Radiopharmaceuticals by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Nuclear Medicine/Radiopharmaceuticals by Country
21.2 East Asia Market Forecasted Consumption of Nuclear Medicine/Radiopharmaceuticals by Country
21.3 Europe Market Forecasted Consumption of Nuclear Medicine/Radiopharmaceuticals by Countriy
21.4 South Asia Forecasted Consumption of Nuclear Medicine/Radiopharmaceuticals by Country
21.5 Southeast Asia Forecasted Consumption of Nuclear Medicine/Radiopharmaceuticals by Country
21.6 Middle East Forecasted Consumption of Nuclear Medicine/Radiopharmaceuticals by Country
21.7 Africa Forecasted Consumption of Nuclear Medicine/Radiopharmaceuticals by Country
21.8 Oceania Forecasted Consumption of Nuclear Medicine/Radiopharmaceuticals by Country
21.9 South America Forecasted Consumption of Nuclear Medicine/Radiopharmaceuticals by Country
21.10 Rest of the world Forecasted Consumption of Nuclear Medicine/Radiopharmaceuticals by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
